Looks like you clickedhttps://www.urotoday.com/conference-highlights/esmo-2019/esmo-2019-prostate-cancer/115274-esmo-2019-phase-ii-study-of-pembrolizumab-with-enzalutamide-in-mcrpc-30-patient-expansion-with-examination-of-tumor-infiltrating-immune-cells-and-fecal-microbiota.html
If you do not want to visit that page, you can close this browser tab.
